Soligenix Receives FDA Orphan Drug Designation For The Active Ingredient In SuVax, The Subunit Protein Vaccine Of Recombinantly Expressed Sudan Ebolavirus (SUDV) Glycoprotein, For The Prevention And Post-Exposure Prophylaxis Against SUDV Infection
Benzinga Newsdesk - Apr 11, 2024, 7:32AM